• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Elafin (PI3)

The recombinant Human PI3 is a yeast-expressed (61-117aa) protein with N-terminal 6xHis tag. The purity is 90%+ measured by SDS-PAGE. The highly developed genetic system, ease of use, reduced time input, and costs have made Pichia Pastoris an attractive organism for the expression and production of recombinant proteins. So we choose the Yeast?system to express this recombinant PI3 protein, which is able to carry specifically designed plasmids, and the plasmid used consists of restriction sites that can be used to insert the gene sequence of interest. Transformation of yeasts with the plasmid produces the desired protein and can be appropriately scaled up.PI3, also called Elafin, is an endogenous serine protease inhibitor that constitutes the epithelial barrier against neutrophil elastase (NE) and protease 3 (PR3). It can reduce airway mucus hypersecretion and decrease inflammatory lung injury. In addition to having protease inhibitory activity, Elafin also exerts several functions such as anti-inflammation, antimicrobe, antiproliferation, immune modulation, vascular remodeling, and wound healing. It is downregulated in several inflammatory diseases, including acute respiratory distress syndrome, inflammatory bowel disease, and acute lung injury. Elafin is differentially expressed in several tumors. Enhanced Elafin expression is associated with the differentiation of esophageal cancer. While downregulation of Elafin is detected in ductal carcinoma in situ, invasion breast cancer, and invasion ovarian cancer.

ACP04823

The recombinant Human PI3 is a yeast-expressed (61-117aa) protein with N-terminal 6xHis tag. The purity is 90%+ measured by SDS-PAGE. The highly developed genetic system, ease of use, reduced time input, and costs have made Pichia Pastoris an attractive organism for the expression and production of recombinant proteins. So we choose the Yeast?system to express this recombinant PI3 protein, which is able to carry specifically designed plasmids, and the plasmid used consists of restriction sites that can be used to insert the gene sequence of interest. Transformation of yeasts with the plasmid produces the desired protein and can be appropriately scaled up.PI3, also called Elafin, is an endogenous serine protease inhibitor that constitutes the epithelial barrier against neutrophil elastase (NE) and protease 3 (PR3). It can reduce airway mucus hypersecretion and decrease inflammatory lung injury. In addition to having protease inhibitory activity, Elafin also exerts several functions such as anti-inflammation, antimicrobe, antiproliferation, immune modulation, vascular remodeling, and wound healing. It is downregulated in several inflammatory diseases, including acute respiratory distress syndrome, inflammatory bowel disease, and acute lung injury. Elafin is differentially expressed in several tumors. Enhanced Elafin expression is associated with the differentiation of esophageal cancer. While downregulation of Elafin is detected in ductal carcinoma in situ, invasion breast cancer, and invasion ovarian cancer.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP04823 Target NamePI3
FormLiquid or Lyophilized powderExpression SystemYeast
Expression Range61-117aaMol Weight8.0kDa
Protein LengthFull Length of Mature ProteinPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP19957
Background Information
  • Uniprot Id

    P19957

  • Target Species

    Human

  • Target Name

    PI3

  • Target Full Name

    Elafin

  • Target Function

    Neutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis. Has been shown to inhibit the alpha-4-beta-2/CHRNA2-CHRNB2 nicotinic acetylcholine receptor and to produce a weak inhibition on Kv11.1/KCNH2/ERG1 and on the transient receptor potential cation channel subfamily V member 1 (TRPV1).

  • Target Subcellular Location

    Secreted.

  • Target Research Area

    Signal Transduction

  • Target Synonyms

    Cementoin; ELAF_HUMAN; Elafin; Elafin/Skalp; Elastase Specific Inhibitor; Elastase-specific inhibitor; ES 1; ESI; Peptidase inhibitor 3; Peptidase inhibitor 3; skin derived; PI 3; PI-3; PI3; Pre elafin; Protease inhibitor 3 skin derived ; Protease inhibitor 3; skin derived (SKALP); Protease inhibitor WAP3; SKALP; Skin derived Anti leukoproteinase; Skin-derived antileukoproteinase; Trappin 2; WAP four disulfide core domain 14; WAP four disulfide core domain protein 14; WAP four-disulfide core domain protein 14; WAP3; WFDC14

  • Target Background

    This gene encodes an elastase-specific inhibitor that functions as an antimicrobial peptide against Gram-positive and Gram-negative bacteria, and fungal pathogens. The protein contains a WAP-type four-disulfide core (WFDC) domain, and is thus a member of the WFDC domain family. Most WFDC gene members are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene belongs to the centromeric cluster. Expression of this gene is upgulated by bacterial lipopolysaccharides and cytokines.

Inquire Recombinant Human Elafin (PI3) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification